Clinical Trial Update: Diabetes Drug Eluting Sirolimus Stent Experience in Restenosis Trial [Phase 4]

View source ↗

Summary

Phase 4 trial update on a sirolimus-eluting stent for restenosis in coronary artery disease; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Rapamune (sirolimus)

Snippet

Sponsor: Cordis US Corp. | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED